# Ketamine and Propofol Combination Versus Propofol for Upper Gastrointestinal Endoscopy

> **NCT02643979** · PHASE4 · TERMINATED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 22 (actual)

## Conditions studied

- Obesity
- Bariatrics
- Sleep Apnea Syndromes
- Gastric Bypass
- Endoscopy

## Interventions

- **DRUG:** Ketofol
- **DRUG:** Propofol
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT02643979
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-01-01
- **Primary completion:** 2019-01-05
- **Final completion:** 2019-01-05
- **Target enrollment:** 22 (ACTUAL)
- **Why stopped:** Lack of Enrollment
- **Last updated:** 2020-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02643979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02643979, "Ketamine and Propofol Combination Versus Propofol for Upper Gastrointestinal Endoscopy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02643979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*